Tim Jansen

11.3k total citations
163 papers, 4.7k citations indexed

About

Tim Jansen is a scholar working on Rheumatology, Nephrology and Surgery. According to data from OpenAlex, Tim Jansen has authored 163 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Rheumatology, 56 papers in Nephrology and 43 papers in Surgery. Recurrent topics in Tim Jansen's work include Rheumatoid Arthritis Research and Therapies (55 papers), Gout, Hyperuricemia, Uric Acid (55 papers) and Case Reports on Hematomas (27 papers). Tim Jansen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (55 papers), Gout, Hyperuricemia, Uric Acid (55 papers) and Case Reports on Hematomas (27 papers). Tim Jansen collaborates with scholars based in Netherlands, United States and United Kingdom. Tim Jansen's co-authors include M. Janssen, Eric N. van Roon, Fernando Pérez-Ruiz, J. R. B. J. Brouwers, Mart A F J van de Laar, Michael Doherty, Thomas Bardin, Eliseo Pascual, Leonardo Punzi and M.K. Reinders and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Tim Jansen

159 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Jansen Netherlands 36 2.2k 1.9k 1.1k 869 624 163 4.7k
Jung‐Yoon Choe South Korea 36 1.9k 0.9× 537 0.3× 669 0.6× 1.0k 1.2× 1.0k 1.7× 218 4.4k
Frank Eitner Germany 43 725 0.3× 2.5k 1.3× 706 0.6× 1.7k 1.9× 1.1k 1.8× 125 5.9k
Kuang‐Hui Yu Taiwan 33 1.4k 0.6× 1.2k 0.6× 875 0.8× 493 0.6× 392 0.6× 122 3.5k
Karl Lhotta Austria 41 530 0.2× 2.3k 1.2× 1.3k 1.1× 629 0.7× 862 1.4× 142 5.1k
Rudolf P. Wüthrich Switzerland 50 709 0.3× 2.3k 1.2× 1.1k 1.0× 2.2k 2.5× 1.5k 2.4× 203 8.4k
Helen Keen Australia 33 2.7k 1.2× 629 0.3× 996 0.9× 266 0.3× 502 0.8× 157 4.1k
J. S. Cameron United Kingdom 39 766 0.4× 2.7k 1.5× 793 0.7× 1.1k 1.3× 605 1.0× 163 5.1k
Cèsar Díaz‐Torné Spain 30 1.0k 0.5× 543 0.3× 596 0.5× 390 0.4× 326 0.5× 153 2.7k
Bernhard Banas Germany 41 509 0.2× 1.4k 0.8× 1.1k 1.0× 1.4k 1.6× 1.6k 2.5× 185 6.0k
Ching‐Yuang Lin Taiwan 34 608 0.3× 665 0.4× 690 0.6× 714 0.8× 721 1.2× 174 4.0k

Countries citing papers authored by Tim Jansen

Since Specialization
Citations

This map shows the geographic impact of Tim Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Jansen more than expected).

Fields of papers citing papers by Tim Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Jansen. The network helps show where Tim Jansen may publish in the future.

Co-authorship network of co-authors of Tim Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Jansen. A scholar is included among the top collaborators of Tim Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Jansen. Tim Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voshaar, Martijn A. H. Oude, et al.. (2025). Treat to Target in Gout Management: A Critical Reappraisal of Current Strategies. University of Twente Research Information. 3(1). 3–3.
2.
Kischkel, Brenda, Pieter J. Emans, Guus van den Akker, et al.. (2024). Discovery of calcite as a new pro-inflammatory calcium-containing crystal in human osteoarthritic synovial fluid. Osteoarthritis and Cartilage. 32(10). 1261–1272. 4 indexed citations
3.
Janssen, M., et al.. (2024). The Prevalence of Titanium Dioxide Particles in Synovial Fluid Samples Drops after European Union Ban. University of Twente Research Information. 2(1). 45–51. 3 indexed citations
4.
Ea, Hang‐Korng, Brenda Kischkel, Viola Klück, et al.. (2024). Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker. Annals of the Rheumatic Diseases. 83(7). 1–12. 13 indexed citations
5.
6.
Efdé, M., et al.. (2023). Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone. SHILAP Revista de lepidopterología. 97–105. 2 indexed citations
7.
Siddiq, Md Abu Bakar, Tim Jansen, & Johannes J. Rasker. (2022). What is the Place for Uricosuric Agents in Gout Management?. Current Rheumatology Reviews. 18(4). 279–285.
8.
Voshaar, Martijn A. H. Oude, et al.. (2019). A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties. Health and Quality of Life Outcomes. 17(1). 63–63. 5 indexed citations
9.
10.
11.
12.
Crișan, Tania O., Maartje C. P. Cleophas, Marije Oosting, et al.. (2015). Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Annals of the Rheumatic Diseases. 75(4). 755–762. 223 indexed citations
13.
Mertens, Jorre S., Marieke M.B. Seyger, Wietske Kievit, et al.. (2014). Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease. British Journal of Dermatology. 172(3). 722–728. 46 indexed citations
14.
Laar, Mart A F J van de, et al.. (2014). Late‐Breaking Abstracts. Arthritis & Rheumatology. 66(12). 3529–3540. 4 indexed citations
15.
Lamers-Karnebeek, F., et al.. (2014). Optimizing the expediency of TNFi in rheumatoid arthritis: offering a TNFi holiday in patients having reached low-disease activity in the maintenance phase. Expert Opinion on Biological Therapy. 14(12). 1761–1767. 7 indexed citations
16.
Schipper, L.G., Monique Hoekstra, T. P. M. Vliet Vlieland, et al.. (2009). Richtlijn 'Diagnostiek en behandeling van reumatoïde artritis'. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 153. 5 indexed citations
17.
Reinders, M.K., Eric N. van Roon, Kris L. L. Movig, et al.. (2007). A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection. Journal of Pharmaceutical and Biomedical Analysis. 45(2). 312–317. 28 indexed citations
18.
Roon, Eric N. van, Monique Hoekstra, Hilde Tobi, et al.. (2005). Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation. British Journal of Clinical Pharmacology. 60(3). 319–325. 10 indexed citations
19.
Reinders, M.K., et al.. (2005). Authors' reply: A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable?. Annals of the Rheumatic Diseases. 64(3). 516–516. 4 indexed citations
20.
Jansen, Tim, et al.. (1998). Dermatomyositis with subclinical myositis and spontaneous pneumomediastinum with pneumothorax: case report and review of the literature.. PubMed. 16(6). 733–5. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jung‐Yoon Choe Breakdown of academic impact, for papers by Frank Eitner Breakdown of academic impact, for papers by Kuang‐Hui Yu Breakdown of academic impact, for papers by Karl Lhotta Breakdown of academic impact, for papers by Rudolf P. Wüthrich Breakdown of academic impact, for papers by Helen Keen Breakdown of academic impact, for papers by J. S. Cameron Breakdown of academic impact, for papers by Cèsar Díaz‐Torné Breakdown of academic impact, for papers by Bernhard Banas Breakdown of academic impact, for papers by Ching‐Yuang Lin
Rankless by CCL
2026